Biblio Discovery — Demo Discovery Service

3 hasil untuk "Matthieu Gregoire"

Menampilkan 1–3 · 0,44 detik · RSS

  1. Artikel Jurnal

    Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy

    Hamza Sayadi; Matthieu Gregoire; Yeleen Fromage dkk.

    Antimicrobial Agents and Chemotherapy, Vol. 70 No. 8 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Dalbavancin is increasingly used off-label for prolonged therapy in gram-positive infections, but optimal repeat-dosing strategies remain undefined, and published population pharmacokinetic (popPK) models lack external validation in real-world cohorts. A popPK model was developed using…

  2. Artikel Jurnal

    Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosing

    Hamza Sayadi; Matthieu Gregoire; Yeleen Fromage dkk.

    Antimicrobial Agents and Chemotherapy, Vol. 70 No. 1 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Dalbavancin is a long-acting lipoglycopeptide increasingly used off-label for complex Gram-positive infections requiring prolonged therapy. Its extended half-life enables simplified regimens, but interindividual pharmacokinetic variability and pathogen MIC heterogeneity complicate dosing…

  3. Artikel Jurnal

    Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections

    Eva Benavent; Jaime Lora-Tamayo; Marta Ulldemolins dkk.

    Antimicrobial Agents and Chemotherapy, Vol. 69 No. 12 · 2025 · Inggris · DOAJ Scopus

    ABSTRACT The efficacy, safety, and population pharmacokinetics of a single 1,500 mg dose of dalbavancin as a sequencing treatment for Gram-positive chronic prosthetic joint infections (CPJIs) have not been described. We present an observational, retrospective study conducted in two Spanish…